244 related articles for article (PubMed ID: 17482562)
1. A novel role of the Batten disease gene CLN3: association with BMP synthesis.
Hobert JA; Dawson G
Biochem Biophys Res Commun; 2007 Jun; 358(1):111-6. PubMed ID: 17482562
[TBL] [Abstract][Full Text] [Related]
2. A galactosylceramide binding domain is involved in trafficking of CLN3 from Golgi to rafts via recycling endosomes.
Persaud-Sawin DA; McNamara JO; Rylova S; Vandongen A; Boustany RM
Pediatr Res; 2004 Sep; 56(3):449-63. PubMed ID: 15240864
[TBL] [Abstract][Full Text] [Related]
3. A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis.
Kitzmüller C; Haines RL; Codlin S; Cutler DF; Mole SE
Hum Mol Genet; 2008 Jan; 17(2):303-12. PubMed ID: 17947292
[TBL] [Abstract][Full Text] [Related]
4. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.
Chan CH; Mitchison HM; Pearce DA
Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598
[TBL] [Abstract][Full Text] [Related]
5. Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex.
Uusi-Rauva K; Luiro K; Tanhuanpää K; Kopra O; Martín-Vasallo P; Kyttälä A; Jalanko A
Exp Cell Res; 2008 Sep; 314(15):2895-905. PubMed ID: 18621045
[TBL] [Abstract][Full Text] [Related]
6. Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function.
Chandrachud U; Walker MW; Simas AM; Heetveld S; Petcherski A; Klein M; Oh H; Wolf P; Zhao WN; Norton S; Haggarty SJ; Lloyd-Evans E; Cotman SL
J Biol Chem; 2015 Jun; 290(23):14361-80. PubMed ID: 25878248
[TBL] [Abstract][Full Text] [Related]
7. Defective lysosomal arginine transport in juvenile Batten disease.
Ramirez-Montealegre D; Pearce DA
Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
[TBL] [Abstract][Full Text] [Related]
8. Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype.
Xiong J; Kielian T
J Neurochem; 2013 Oct; 127(2):245-58. PubMed ID: 23919525
[TBL] [Abstract][Full Text] [Related]
9. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.
Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA
Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady.
Shematorova EK; Shpakovski DG; Chernysheva AD; Shpakovski GV
Biol Direct; 2018 Sep; 13(1):19. PubMed ID: 30621751
[TBL] [Abstract][Full Text] [Related]
11. CLN3p impacts galactosylceramide transport, raft morphology, and lipid content.
Rusyn E; Mousallem T; Persaud-Sawin DA; Miller S; Boustany RM
Pediatr Res; 2008 Jun; 63(6):625-31. PubMed ID: 18317235
[TBL] [Abstract][Full Text] [Related]
12. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
Chan CH; Ramirez-Montealegre D; Pearce DA
Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue.
Pohl S; Mitchison HM; Kohlschütter A; van Diggelen O; Braulke T; Storch S
J Neurochem; 2007 Dec; 103(6):2177-88. PubMed ID: 17868323
[TBL] [Abstract][Full Text] [Related]
14. Osmoregulation of ceroid neuronal lipofuscinosis type 3 in the renal medulla.
Stein CS; Yancey PH; Martins I; Sigmund RD; Stokes JB; Davidson BL
Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1388-400. PubMed ID: 20219947
[TBL] [Abstract][Full Text] [Related]
15. Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway.
Luiro K; Yliannala K; Ahtiainen L; Maunu H; Järvelä I; Kyttälä A; Jalanko A
Hum Mol Genet; 2004 Dec; 13(23):3017-27. PubMed ID: 15471887
[TBL] [Abstract][Full Text] [Related]
16. A novel in-frame mutation in
Sher M; Farooq M; Abdullah U; Ali Z; Faryal S; Zakaria M; Ullah F; Bukhari H; Møller RS; Tommerup N; Baig SM
Int J Neurosci; 2019 Sep; 129(9):890-895. PubMed ID: 30892110
[No Abstract] [Full Text] [Related]
17. Altered sensitivity of cerebellar granule cells to glutamate receptor overactivation in the Cln3(Δex7/8)-knock-in mouse model of juvenile neuronal ceroid lipofuscinosis.
Finn R; Kovács AD; Pearce DA
Neurochem Int; 2011 May; 58(6):648-55. PubMed ID: 21315126
[TBL] [Abstract][Full Text] [Related]
18. Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system.
Staropoli JF; Haliw L; Biswas S; Garrett L; Hölter SM; Becker L; Skosyrski S; Da Silva-Buttkus P; Calzada-Wack J; Neff F; Rathkolb B; Rozman J; Schrewe A; Adler T; Puk O; Sun M; Favor J; Racz I; Bekeredjian R; Busch DH; Graw J; Klingenspor M; Klopstock T; Wolf E; Wurst W; Zimmer A; Lopez E; Harati H; Hill E; Krause DS; Guide J; Dragileva E; Gale E; Wheeler VC; Boustany RM; Brown DE; Breton S; Ruether K; Gailus-Durner V; Fuchs H; de Angelis MH; Cotman SL
PLoS One; 2012; 7(6):e38310. PubMed ID: 22701626
[TBL] [Abstract][Full Text] [Related]
19. Juvenile neuronal ceroid-lipofuscinosis (Batten disease): a brief review and update.
Rakheja D; Narayan SB; Bennett MJ
Curr Mol Med; 2007 Sep; 7(6):603-8. PubMed ID: 17896996
[TBL] [Abstract][Full Text] [Related]
20. The CLN3 gene and protein: What we know.
Mirza M; Vainshtein A; DiRonza A; Chandrachud U; Haslett LJ; Palmieri M; Storch S; Groh J; Dobzinski N; Napolitano G; Schmidtke C; Kerkovich DM
Mol Genet Genomic Med; 2019 Dec; 7(12):e859. PubMed ID: 31568712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
